MoneyWorks4Me

SMS Lifesciences - Quaterly Results

10 Feb 2023 Evaluate
The revenue slipped marginally during the December 2022 quarter. A decline of about Rs. 907.57 millions was observed as compared to Rs. 926.88 millions during the corresponding quarter last year.The Net proft of the company remain more or less same to Rs. 40.11  millions from Rs. 42.98 millions ,decline by -6.68%.Operating Profit reported a sharp decline to 87.13 millions from 90.07 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 907.57 926.88 -2.08 2496.90 2506.68 -0.39 3456.28 2602.56 32.80
Other Income 5.03 0.26 1834.62 9.34 7.22 29.36 15.36 13.33 15.23
PBIDT 87.13 90.07 -3.26 244.80 246.13 -0.54 329.00 310.68 5.90
Interest 12.59 10.02 25.65 36.81 33.84 8.78 46.25 45.00 2.78
PBDT 74.54 80.05 -6.88 207.99 290.01 -28.28 409.67 265.68 54.20
Depreciation 20.29 19.91 1.91 60.56 60.24 0.53 79.90 72.13 10.77
PBT 54.25 60.14 -9.79 147.43 229.77 -35.84 329.77 193.55 70.38
TAX 14.14 17.16 -17.60 39.91 60.39 -33.91 75.96 61.86 22.79
Deferred Tax -0.86 0.16 -637.50 -2.59 0.39 -764.10 0.36 11.59 -96.89
PAT 40.11 42.98 -6.68 107.52 169.38 -36.52 253.81 131.69 92.73
Equity 30.23 30.23 0.00 30.23 30.23 0.00 30.23 30.23 0.00
PBIDTM(%) 9.60 9.72 -1.21 9.80 9.82 -0.15 9.52 11.94 -20.26
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..